Client News
Biom’up appoints George Makhoul as Chief Commercial Officer (USA)
31st January 2019
HPS Home Power Solutions GmbH announces launch of WIWIN crowdfunding campaign
30th January 2019
Biom’up HEMOBLASTTM Bellows full pivotal trial results published in Journal of Cardiac Surgery
30th January 2019
Rentschler Biopharma SE appoints Dr. Christian Hunzinger as Senior Vice President Project Management
29th January 2019
Abivax Publishes in Nature Scientific Reports ABX464’s Unique Mechanism of Action Leading to Both Anti-Inflammatory and Antiviral Effects
28th January 2019
HPS Home Power Solutions GmbH announces first closing of its financing round at € 7.5 million
24th January 2019
Ergomed plc: Board and Management Changes
23rd January 2019
Abivax Hosts KOL Event in Geneva on Therapeutic Candidate ABX464 for Ulcerative Colitis
23rd January 2019
nova funds: Gesundheitsaktienfonds nova Steady HealthCare erzielt 2018 erneut sehr gutes Ergebnis
17th January 2019
Medigene AG: Medigene participates at four upcoming conferences
17th January 2019
Allergy Therapeutics announces business development ppdate and publication date of half year results for FY 2018/2019
16th January 2019
Newron Pharmaceuticals: Commercialization partner Zambon together with Valeo Pharma announce the approval of Onstryv® (safinamide) for Parkinson’s disease in Canada
16th January 2019
Adocia confirms its financial calendar for 2019
16th January 2019
Verona Pharma Reports Encouraging Top-Line Data from Three-Day Phase 2 Trial Evaluating Nebulized Ensifentrine (RPL554) on Top of Dual Bronchodilator Therapy for COPD Maintenance
14th January 2019
Verona Pharma Receives WHO Approval for “ensifentrine” as Recommended INN for RPL554
10th January 2019
HPS Home Power Solutions GmbH begins delivery of the first Picea customer systems
9th January 2019
Medigene AG: Additional European patent granted for Medigene’s DC vaccine platform
8th January 2019
Expedeon AG licenses Lightning-Link® Rapid Biotinylation technology to Cell Guidance Systems in supply agreement
8th January 2019
Sterna biologicals prepares for phase IIb clinical program with GATA-3 antagonist drug candidates SB010 in asthma and SB012 in ulcerative colitis
8th January 2019
AYOXXA signs research agreement in the field of ophthalmology with one of the leading pharmaceutical companies
8th January 2019
Molecular Health licenses its proprietary predictive analytics to DATEN CAPITAL
7th January 2019
Biom’up: Achievement of two major development milestones
7th January 2019
Rentschler Biopharma completes acquisition of U.S. manufacturing site
3rd January 2019
InflaRx continues U.S. expansion with addition of New York City corporate office and addition of management
3rd January 2019
Verona Pharma appoints Kathleen Rickard, MD, as chief medical officer to lead late stage clinical development of RPL554
3rd January 2019
Atriva Therapeutics announces first closing of series A financing round
3rd January 2019
